Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Biome Australia Ltd ( (AU:BIO) ) is now available.
Biome Australia Limited reported record sales revenue for the quarter ending June 2025, with a significant increase in both quarterly and annual sales figures. The company achieved a quarterly EBITDA of $78k and anticipates exceeding $900k for the fiscal year 2025. Despite a net operating cash outflow, Biome increased its cash balance and maintained a gross margin of 61%. Strategic investments were made to support future growth, including the launch of a new product range and international market expansion.
The most recent analyst rating on (AU:BIO) stock is a Buy with a A$0.85 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Limited is a microbiome health company that focuses on developing and marketing products related to microbiome health. The company is listed on the Australian Securities Exchange (ASX) under the ticker BIO and is involved in both Australian and international markets.
Average Trading Volume: 357,340
Technical Sentiment Signal: Strong Buy
See more insights into BIO stock on TipRanks’ Stock Analysis page.